NBC Securities’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$37.7K Buy
276
+107
+63% +$13.1K ﹤0.01% 1400
2026
Q1
$19.9K Hold
169
﹤0.01% 1710
2025
Q4
$27.7K Sell
169
-35
-17% -$5.48K ﹤0.01% 1621
2025
Q3
$27.3K Sell
204
-285
-58% -$34.6K ﹤0.01% 1582
2025
Q2
$60K Sell
489
-2,185
-82% -$278K ﹤0.01% 1243
2025
Q1
$340K Buy
2,674
+2,672
+133,600% +$411K 0.03% 581
2024
Q4
$408 Sell
2
-2,929
-100% -$420K 0.04% 514
2024
Q3
$436K Buy
2,931
+1,406
+92% +$202K 0.04% 509
2024
Q2
$192K Buy
1,525
+1,396
+1,082% +$219K 0.02% 765
2024
Q1
$23K Hold
129
﹤0.01% 1409
2023
Q4
$23K Hold
129
﹤0.01% 1421
2023
Q3
$20K Buy
+129
New +$21.1K ﹤0.01% 1452

Other funds holding RGEN

NBC Securities's RGEN Position: Q2 2026 in Review

NBC Securities increased its Repligen (RGEN) stake by 63% in Q2 2026, buying an estimated $13.1K and bringing the position to 276 shares worth $37.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1400.

NBC Securities first reported a position in RGEN in Q3 2023 and has held it in 12 quarters since. The position peaked at $436K in Q3 2024. 482 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

  • NBC Securities held 276 shares of Repligen worth $37.7K as of Q2 2026.
  • NBC Securities bought 107 Repligen shares in Q2 2026, an estimated $13.1K.
  • Repligen made up ﹤0.01% of NBC Securities's portfolio in Q2 2026, its #1400 holding.
  • NBC Securities first reported a position in Repligen in Q3 2023 and has held it in 12 quarters since.
  • NBC Securities's Repligen position peaked at $436K in Q3 2024.
  • 482 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on NBC Securities's 13F filing for Q2 2026, filed 21 Jul 2026.